Recent Finacing
Recent Raise
Cue Biopharma develops engineered biologics combining peptide–MHC TCR targeting with engineered co-stimulatory ligands on antibody scaffolds to selectively modulate disease-relevant T cell subsets across oncology and autoimmune indications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor